이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1998. 10. 8.1 분 읽기
Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is amending its regulations governing the submission and review of premarket approval (PMA) supplements to provide for the submission of a 30-day notice for modifications to manufacturing procedures or methods of manufacture. Amendments are being made to implement revisions to the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Food and Drug Administration Modernization Act of 1997 (FDAMA).
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →